Trial Profile
Efficacy and safety of pregabalin for the treatment of neuropathic pain in patients undergoing hemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 25 Oct 2016 New trial record
- 23 Sep 2016 Results assessing safety and efficacy published in the Clinical Drug Investigation.